00000nam 2200000zi 4500 9.917914 CaOODSP 20230104110146 m o d f cr mn||||||||| 221201e20220614onca ob f000 0 eng d CaOODSP eng rda CaOODSP n-cn--- YN5-258/2022E-PDF Canadian patented drug prices : gauging the change in reference countries. [Ottawa] : Office of the Parliamentary Budget Officer = Bureau du Directeur parlementaire du budget, June 14, 2022. ©2022 1 online resource (20 pages) : colour illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Prix canadiens des médicaments brevetés : mesurer l'importance de la modification dans les pays de référence. "RP-2223-008-S_e." Includes bibliographical references. "The Parliamentary Budget Officer (PBO) supports Parliament by providing economic and financial analysis for the purposes of raising the quality of parliamentary debate and promoting greater budget transparency and accountability. Regulatory changes for how the Patented Medicines Prices Review Board (PMPRB) formulates price ceilings for patented drugs have been proposed and are due to come into effect in July of 2022. This report examines the proposed change and quantifies its long-term impact. We find that a change to the median of eleven comparator countries is important, but that more flexibility to re-adjust prices would potentially contribute more to reducing expenditures by Canadians." Patent medicines Prices Canada. Patent medicines Prices Law and legislation Canada. Canada. Office of the Parliamentary Budget Officer, issuing body. Prix canadiens des médicaments brevetés : (CaOODSP)9.917915 PDF 318 KB https://publications.gc.ca/collections/collection_2023/dpb-pbo/YN5-258-2022-eng.pdf